Latest

Diabetes therapy

GLP-1 Receptor Polymorphism Alters Efficacy of Liraglutide Treatment in Individuals with Obesity

Researchers at Vanderbilt University Medical Center have identified a genetic variant in the glucagon-like peptide-1 receptor (GLP-1R) that influences the effectiveness of liraglutide, a medication used to treat obesity and pre-diabetes. The study, published in the Journal of Endocrinology, found that individuals with the variant allele (rs6923761) experienced greater weight